封面
市場調查報告書
商品編碼
2132471

醫療保健資料貨幣化市場規模、佔有率和趨勢分析報告:按產品類型、資料來源、應用、最終用途、地區和細分市場預測(2026-2033 年)

Healthcare Data Monetization Market Size, Share & Trends Analysis Report By Product Type (Data Subscription, Insights-as-a-Service, Models/Decision Engines), By Data Source, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

醫療保健數據貨幣化市場概述

全球醫療保健數據貨幣化市場預計到 2025 年將達到 20 億美元,到 2026 年將成長到 21 億美元,到 2033 年將達到 37 億美元,2026 年至 2033 年的複合年成長率為 8.2%。

北美是市場主導,預計到 2025 年將佔銷售額的 51.8%。這一成長是由電子健康記錄 (EHR)、電子病歷 (EMR)、醫院資訊系統 (HIS)、實驗室資訊系統 (LIS) 和數位影像平台的普及所推動的,從而導致結構化和非結構化醫療保健數據的急劇增加。

醫療服務提供者和保險公司正擴大利用這些資料集,透過分析服務、許可、基準測試和增值見解來創造額外收入。

目錄

第1章:調查方法和範圍

第2章執行摘要

第3章 市場:變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 商業環境分析

第4章:醫療數據貨幣化市場:按產品類型分類的估算與趨勢分析

  • 按產品類型分類的市場佔有率和趨勢分析(2025 年和 2033 年)
  • 市場規模、預測與趨勢分析:按產品類型分類,2021-2033 年
  • 資料訂閱(患者層級/匯總資料/授權資料集)
  • 洞察即服務(精選分析產品)
  • 模型/決策引擎(利用人工智慧的預測產品)

第5章:醫療資料貨幣化市場:依資料來源分類的估算與趨勢分析

  • 按資料來源分類的市場佔有率和趨勢分析(2025 年和 2033 年)
  • 市場規模、預測與趨勢分析:依資料來源分類,2021-2033年
  • 計費數據
  • 電子健康記錄/電子病歷數據
  • 藥房數據
  • 基因組數據
  • 患者產生的健康數據
  • 影像資料
  • 測試數據
  • 整合數據資產
  • 其他

第6章:醫療數據貨幣化市場:按應用領域分類的估算與趨勢分析

  • 應用模式儀錶板
  • 按應用領域分類的市場佔有率和趨勢分析(2025 年和 2033 年)
  • 市場規模、預測與趨勢分析:按應用領域分類,2021-2033年
  • 安全性、用藥依從性和衛生經濟學/結果研究(HEOR)
  • 品質改善和縮小護理差距
  • 網路和營運最佳化
  • 市場進入和商業策略
  • 臨床研究與臨床試驗支持
  • 目標客戶為醫療保健專業人員 (HCP) 和顧客
  • 其他

第7章:醫療數據貨幣化市場:依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率和趨勢分析(2025 年和 2033 年)
  • 市場規模、預測和趨勢分析:按最終用途分類,2021-2033 年
  • 製藥公司
  • 醫療服務提供方
  • 生技公司
  • 研究機構
  • 醫療保健支付方
  • 醫療設備製造商
  • 政府機構
  • 其他

第8章:醫療數據貨幣化市場:區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場:要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 參與企業概況
  • 2025年公司市場分析
  • 公司分類
  • 策略規劃
  • 公司簡介列表
    • IQVIA
    • Oracle
    • Optum
    • Veradigm
    • Komodo Health
    • Cotiviti
    • Inovalon
    • HealthVerity
    • Truveta
    • Datavant
    • Innovaccer
    • COTA
    • Flatiron Health
    • Tempus AI
Product Code: GVR-4-68040-140-0

Healthcare Data Monetization Market Summary

The global healthcare data monetization market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.1 billion in 2026 to USD 3.7 billion by 2033, at a CAGR of 8.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 51.8% in 2025. This growth is attributed to the widespread adoption of Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Hospital Information Systems (HIS), Laboratory Information Systems (LIS), and digital imaging platforms, which has resulted in an exponential increase in structured and unstructured healthcare data.

Healthcare providers and payers are increasingly leveraging these datasets to generate additional revenue through analytics services, licensing, benchmarking, and value-added insights.

Global Healthcare Data Monetization Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare data monetizationmarket report based on product type, data source, application, end use and regions.

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Data Subscription (patient-level / aggregate / licensed datasets)
  • Insights-as-a-Service (curated analytics products)
  • Models / Decision Engines (AI-enabled predictive products)
  • Data Source Outlook (Revenue, USD Million, 2021 - 2033)
  • Claims Data
  • EHR/EMR Data
  • Pharmacy Data
  • Genomics Data
  • Patient-Generated Health Data
  • Imaging Data
  • Laboratory Data
  • Integrated Data Assets
  • Others (Social Determinants of Health (SDoH) Data, Behavioral Data, Survey and Patient-Reported Data)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Safety, Adherence & Health Economics and Outcomes Research (HEOR)
  • Quality Improvement & Care Gap Closure
  • Network & Operational Optimization
  • Market Access & Commercial Strategy
  • Clinical Research & Trial Enablement
  • HCP & Customer Targeting
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical Companies
  • Healthcare Providers
  • Biotechnology Firms
  • Research Institutions
  • Healthcare Payers
  • Medical Device Manufacturers
  • Government Agencies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Data Source
    • 1.2.3. Application
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Commercialization of De-identified and Longitudinal Patient Data Assets
      • 3.2.1.2. Growing Utilization of Integrated and Multi-Modal Data Assets
      • 3.2.1.3. Growing Demand for Real-World Evidence (RWE) and HEOR Studies
      • 3.2.1.4. Expansion of Precision Medicine and Personalized Therapeutics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data privacy, security, and regulatory compliance concerns (HIPAA, GDPR, etc.)
      • 3.2.2.2. Challenges related to healthcare data quality, standardization, and interoperability across disparate systems
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. Healthcare Data Monetization Market: Product Type Estimates & Trend Analysis

  • 4.1. Product Type Segment Dashboard
  • 4.2. Product Type Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
  • 4.4. Data Subscription (patient-level / aggregate / licensed datasets)
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Insights-as-a-Service (curated analytics products)
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Models/Decision Engines (AI-enabled predictive products)
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Healthcare Data Monetization Market: Data Source Estimates & Trend Analysis

  • 5.1. Data Source Segment Dashboard
  • 5.2. Data Source Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Data Source, 2021 to 2033 (USD Million)
  • 5.4. Claims Data
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. EHR/EMR Data
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Pharmacy Data
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Genomics Data
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Patient-Generated Health Data
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Imaging Data
    • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Laboratory Data
    • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Integrated Data Assets
    • 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Others
    • 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Healthcare Data Monetization Market: Application Estimates & Trend Analysis

  • 6.1. Application Mode Dashboard
  • 6.2. Application Market Share Movement Analysis, 2025 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Safety, Adherence & Health Economics and Outcomes Research (HEOR)
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Quality Improvement & Care Gap Closure
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Network & Operational Optimization
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Market Access & Commercial Strategy
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Clinical Research & Trial Enablement
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. HCP & Customer Targeting
    • 6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Healthcare Data Monetization Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical Companies
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Healthcare Providers
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Biotechnology Firms
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Research Institutions
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Healthcare Payers
    • 7.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Medical Device Manufacturers
    • 7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.10. Government Agencies
    • 7.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.11. Others
    • 7.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Healthcare Data Monetization Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market: Key Takeaways
  • 8.3. North America
    • 8.3.1. North America healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamic
      • 8.3.2.2. Regulatory framework
      • 8.3.2.3. Competitive insights
      • 8.3.2.4. U.S. healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamic
      • 8.3.3.2. Regulatory framework
      • 8.3.3.3. Competitive insights
      • 8.3.3.4. Canada healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamic
      • 8.3.4.2. Regulatory framework
      • 8.3.4.3. Competitive insights
      • 8.3.4.4. Mexico healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamic
      • 8.4.2.2. Regulatory framework
      • 8.4.2.3. Competitive insights
      • 8.4.2.4. Germany healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. UK
      • 8.4.3.1. Key country dynamic
      • 8.4.3.2. Regulatory framework
      • 8.4.3.3. Competitive insights
      • 8.4.3.4. UK healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamic
      • 8.4.4.2. Regulatory framework
      • 8.4.4.3. Competitive insights
      • 8.4.4.4. France healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamic
      • 8.4.5.2. Regulatory framework
      • 8.4.5.3. Competitive insights
      • 8.4.5.4. Italy healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamic
      • 8.4.6.2. Regulatory framework
      • 8.4.6.3. Competitive insights
      • 8.4.6.4. Spain healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key country dynamic
      • 8.4.7.2. Regulatory framework
      • 8.4.7.3. Competitive insights
      • 8.4.7.4. Denmark healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key country dynamic
      • 8.4.8.2. Regulatory framework
      • 8.4.8.3. Competitive insights
      • 8.4.8.4. Sweden healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamic
      • 8.4.9.2. Regulatory framework
      • 8.4.9.3. Competitive insights
      • 8.4.9.4. Norway healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamic
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive insights
      • 8.5.2.4. Japan healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key country dynamic
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive insights
      • 8.5.3.4. China healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamic
      • 8.5.4.2. Regulatory framework
      • 8.5.4.3. Competitive insights
      • 8.5.4.4. India healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamic
      • 8.5.5.2. Regulatory framework
      • 8.5.5.3. Competitive insights
      • 8.5.5.4. South Korea healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamic
      • 8.5.6.2. Regulatory framework
      • 8.5.6.3. Competitive insights
      • 8.5.6.4. Australia healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamic
      • 8.5.7.2. Regulatory framework
      • 8.5.7.3. Competitive insights
      • 8.5.7.4. Thailand healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Healthcare Data Monetization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamic
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive insights
      • 8.6.2.4. Brazil healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamic
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive insights
      • 8.6.3.4. Argentina healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamic
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive insights
      • 8.7.2.4. South Africa healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamic
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive insights
      • 8.7.3.4. Saudi Arabia healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamic
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive insights
      • 8.7.4.4. UAE healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamic
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive insights
      • 8.7.5.4. Kuwait healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis, 2025
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. IQVIA
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Oracle
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Optum
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Veradigm
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Komodo Health
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Cotiviti
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Inovalon
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. HealthVerity
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Truveta
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Datavant
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Innovaccer
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. COTA
      • 9.5.12.1. Overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Flatiron Health
      • 9.5.13.1. Overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. Tempus AI
      • 9.5.14.1. Overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product benchmarking
      • 9.5.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 North America healthcare data monetization market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 5 North America healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 6 North America healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 7 North America healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 8 U.S. healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 9 U.S. healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 10 U.S. healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 11 U.S. healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Canada healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 13 Canada healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 14 Canada healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 15 Canada healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 17 Mexico healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 18 Mexico healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 19 Mexico healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Europe healthcare data monetization market, by country, 2021 - 2033 (USD Million)
  • Table 21 Europe healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 22 Europe healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 23 Europe healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 24 Europe healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 25 Germany healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 26 Germany healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 27 Germany healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 28 Germany healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 30 UK healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 31 UK healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 32 UK healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 33 France healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 34 France healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 35 France healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 36 France healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Italy healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 38 Italy healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 39 Italy healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 40 Italy healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Spain healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 42 Spain healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 43 Spain healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 44 Spain healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific healthcare data monetization market, by country, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 50 China healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 51 China healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 52 China healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 53 China healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 55 Japan healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 56 Japan healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 57 Japan healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 58 India healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 59 India healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 60 India healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 61 India healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 62 South Korea healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 63 South Korea healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 64 South Korea healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 65 South Korea healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Latin America healthcare data monetization market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 68 Latin America healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 69 Latin America healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 70 Latin America healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 71 Brazil healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 72 Brazil healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 73 Brazil healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 74 Brazil healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 75 MEA healthcare data monetization market, by country, 2021 - 2033 (USD Million)
  • Table 76 MEA healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 77 MEA healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 78 MEA healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 79 MEA healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 80 South Africa healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 81 South Africa healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 82 South Africa healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 83 South Africa healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 88 UAE healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 89 UAE healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 90 UAE healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 91 UAE healthcare data monetization market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait healthcare data monetization market, by data source, 2021 - 2033 (USD Million)
  • Table 93 Kuwait healthcare data monetization market, by product type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait healthcare data monetization market, by application, 2021 - 2033 (USD Million)
  • Table 95 Kuwait healthcare data monetization market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Healthcare data monetization market: Market outlook
  • Fig. 5 Healthcare data monetization market: Segment outlook
  • Fig. 6 Healthcare data monetization market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Healthcare data monetization Market Driver Impact
  • Fig. 9 Healthcare data monetization market restraint impact
  • Fig. 10 Healthcare Data Monetization market, Product type outlook key takeaways (USD Million)
  • Fig. 11 Healthcare data monetization market: Product type movement analysis (USD Million)
  • Fig. 12 Data Subscription (patient-level / aggregate / licensed datasets) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Insights-as-a-Service (curated analytics products) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Models / Decision Engines (AI-enabled predictive products) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Healthcare data monetization market, data source outlook: Key takeaways, USD Million
  • Fig. 16 Healthcare data monetization market: Data source movement analysis, USD Million
  • Fig. 17 Claims Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 EHR/EMR Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Pharmacy Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Genomics Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Patient-Generated Health Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Imaging Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Laboratory Data market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Integrated Data Assets market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Healthcare data monetization market: Application movement analysis, USD Million
  • Fig. 27 Safety, Adherence & Health Economics and Outcomes Research (HEOR) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Quality Improvement & Care Gap Closure market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Network & Operational Optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Market Access & Commercial Strategy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Clinical Research & Trial Enablement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 HCP & Customer Targeting market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Healthcare data monetization market, end use outlook key takeaways (USD Million)
  • Fig. 35 Healthcare data monetization market: end use movement analysis, USD Million
  • Fig. 36 Pharmaceutical Companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Healthcare Providers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Biotechnology Firms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Research Institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Healthcare Payers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Medical Device Manufacturers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Government Agencies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional marketplace: Key takeaways
  • Fig. 45 Healthcare data monetization market: Regional outlook, 2025 & 2033
  • Fig. 46 North America healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 US healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Canada healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Mexico healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Europe healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 UK healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Germany healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 France healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Italy healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Spain healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Asia Pacific healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Japan healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 China healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 India healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 South Korea healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 MEA healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 South Africa healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Saudi Arabia healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 UAE healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Kuwait healthcare data monetization market estimates and forecasts, 2021 - 2033 (USD Million)